[PDF][PDF] DIRECT ORAL ANTICOAGULANTS (DOACs) USE IN PATIENTS WITH RENAL INSUFFICIENCY AND OBESITY
EM Nwanosike - 2023 - pure.hud.ac.uk
Abstract The popularity of Direct Oral AntiCoagulants (DOACs) for approved indications has
risen dramatically following their introduction to the UK's National Health Service (NHS) due …
risen dramatically following their introduction to the UK's National Health Service (NHS) due …
Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
SR Gilyarevsky, NK Vereina… - Rational …, 2023 - rpcardio.elpub.ru
The article is devoted to the discussion of modern approaches to the use of laboratory
methods to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical …
methods to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical …
THE EFFECT OF OBESITY ON RIVAROXABAN PHARMACOKINETICS AND PHARMACODYNAMICS
M ALALAWNEH - 2024 - qspace.qu.edu.qa
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary
embolism (PE), is a prevalent condition that is associated with high rates of morbidity and …
embolism (PE), is a prevalent condition that is associated with high rates of morbidity and …
Доклад ERS по хронической тромбоэмболической легочной гипертензии
М Делькруа, А Торбицки, Д Гопалан… - …, 2022 - journal.pulmonology.ru
Аннотация Хроническая тромбоэмболическая (ХТЭ) легочная гипертензия (ЛГ)–редкое
осложнение острой тромбоэмболии легочной артерии (ТЭЛА)–как симптоматической …
осложнение острой тромбоэмболии легочной артерии (ТЭЛА)–как симптоматической …
Management of Portal Vein Thrombosis Following Bariatric Surgery
G Jester, JB Jacob, S Baidas - Duodenal Switch and Its Derivatives in …, 2023 - Springer
Portal vein thrombosis is a rare but serious complication of bariatric surgery. In this chapter,
we will broadly overview issues related to anticoagulation of obese patients and effects of …
we will broadly overview issues related to anticoagulation of obese patients and effects of …
Recurrent Thrombi in an Obese Patient With History of Bariatric Surgery Despite Anti-Xa Therapy
R Briggler, E Matherne, C Johnson… - Journal of Pharmacy …, 2022 - journals.sagepub.com
Obesity and gastric bypass surgery can complicate anticoagulation therapy. In general,
patients post-bariatric surgery are considered to be at a moderate risk for deep venous …
patients post-bariatric surgery are considered to be at a moderate risk for deep venous …
[HTML][HTML] Survivin Signal
OS Costa, J Beyer-Westendorf, V Ashton, D Milentijevic… - survivinsignal.com
Background: Although rivaroxaban has demonstrated consistent drug levels in normal
weight and obese patients, sufficient confirmation of equal clinical effectiveness and safety is …
weight and obese patients, sufficient confirmation of equal clinical effectiveness and safety is …
[PDF][PDF] Le traitement de la maladie thromboembolique veineuse: enjeux et nouveautés
V Mai - 2021 - corpus.ulaval.ca
Résumé Introduction: La maladie thromboembolique veineuse (MTEV) est très fréquente.
Les anticoagulants oraux (AOD) ont démontré leur supériorité dans le traitement aigu de …
Les anticoagulants oraux (AOD) ont démontré leur supériorité dans le traitement aigu de …
[HTML][HTML] Obesidad y fibrilación auricular
S Balamane - siacardio.com
En este artículo de revisión de European Heart Journal Cardiovascular Pharmacotherapy,
Saad Javed y cols. analizan la asociación, posibles mecanismos fisiopatológicos …
Saad Javed y cols. analizan la asociación, posibles mecanismos fisiopatológicos …